- Case report
- Open Access
Retroperitoneal paravertebral ganglioneuroma: a multidisciplinary approach facilitates less radical surgery
© The Author(s). 2016
- Received: 1 April 2016
- Accepted: 20 July 2016
- Published: 26 July 2016
Ganglioneuroma (GN) of the adult is a rare benign tumour originating from neural crest-derived cells. In most cases, GN is found in the mediastinum or retroperitoneum incidentally and may present with unspecific symptoms caused by space-occupying effects. The correct diagnosis of a retroperitoneal mass is still a challenge. Nevertheless, a preoperatively confirmed diagnosis of GN may support the concept of a less radical approach and may help to prevent unnecessary morbidity or loss of function.
We report a case of a symptomatic retroperitoneal paravertebral GN in a 33-year-old woman. She has been referred with abdominal discomfort, lancinating pain in the right leg, headache and nausea. Magnetic resonance imaging revealed a solid paravertebral tumour adjacent to the psoas muscle. Computed tomography-guided core needle biopsy yielded the diagnosis of GN. The tumour was resected completely via a laparotomy. Immunohistopathological examinations confirmed a benign GN.
Diagnostic studies and therapeutic interventions of retroperitoneal GN are discussed. In our case, a core needle biopsy preceding complete resection was helpful to prevent too extensive surgical approach.
- Retroperitoneal tumour
- Paravertebral tumour
Benign ganglioneuroma (GN) contains mature autonomic ganglion cells including satellite cells and long axonal processes as well as Schwann cells [1–3]. Those tumours originate from neural crest-derived cells which form the adrenal medulla and the sympathetic nervous system during embryonic development. Hence, they mainly arise in the mediastinum, retroperitoneum and pelvis where sympathetic ganglia are localized. Alike neuroblastoma and ganglioneuroblastoma, GN is supposed to represent the most mature neuroblastic tumour since ganglion cells that originate from neuroblasts are present in all of these tumours. Maturation of a neuroblastoma into a ganglioneuroma or ganglioneuroblastoma has been commonly described in the literature [1–3].
GN occurs in children and young adults, and median age at diagnosis is 7 years [4–7]. Distribution between males and females vary from a preference of the female gender  to no gender difference . A higher frequency is reported in patients with multiple endocrine neoplasia type II and neurofibromatosis type 1. Due to their slow growth, most GNs are found incidentally. Most patients experience long-term disease-free survival even after incomplete resection [5, 7]. Malignant transformation is rare . Since only a minority of GN are functional, distinct clinical symptoms are missing [4, 5]. Rarely, these tumours may produce hormones, such as catecholamines, vasointestinal peptides and androgens . Radiographically, GN usually present as well-defined solid masses and do not contain cysts as opposed to neuroblastoma and ganglioneuroblastoma [6, 9]. Non-enhancement or slight enhancement in arterial phase and progressive mild enhancement in delayed phase is seen [6, 10]. At MR imaging, GN has low signal intensity on T1-weighted images and high signal intensity on T2 weighted images . Distinct radiological features are lacking. Therefore, diagnosis can be challenging and is more precisely achieved by histological examination after resection. An imaging-guided core needle biopsy can be a reasonable approach to enable a reliable diagnosis before major surgery.
Institutional interdisciplinary tumour board recommended a primary surgical resection. Prior to surgery, a double J stent was placed in the right ureter. Explorative laparotomy exposed the paravertebral tumour extending to the lower pole of the right kidney. The uterus and the adnexa with ovaries were without any pathological findings. After ureterolysis, the tumour was cautiously dissected from adherent structures such as the right common iliac vein and the kidney which were both not infiltrated by the tumour. Finally, the tumour was completely removed by means of blunt and sharp dissection and bipolar coagulation under a surgical microscope (the microscope has been used to save most of the branches of the lumbar plexus and nerves of the sympathetic trunk which was partly incorporated into the GN).
The postoperative course was uneventful. After surgery, the patient reported heat sensations of stocking distribution in the right lower leg. Follow-up 4 months after surgery still revealed a small hyperthermic area and stocking-like heat sensations in the right lower leg that was interpreted to relate to a lesion of the sympathetic trunk partly incorporated into the GN. MRI at follow-up did not show tumour recurrence.
Clinical manifestations of GNs are diverse. In most cases, symptoms result from compression or displacement by the growing tumour and represent disturbances such as disruption of venous flow  and lower abdominal pain . Most GNs are located mediastinal or retroperitoneal. In addition, a primary intraosseous GN of the sacrum has been described as a rare manifestation . GN usually represents a non-secreting tumour. Occasionally, GN may release hormones that can cause diarrhoea, sweating and arterial hypertension . Tumours may also cause tenesmuses and weight loss . In our case, we additionally observed lancinating pain in a leg most likely caused by irritation of branches of the lumbar plexus running along the anterior surface of the psoas muscle.
Important differential diagnoses of retroperitoneal masses like the GN are retroperitoneal soft tissue sarcoma, and retroperitoneal fibrosis, and rarely lymphoma, a primary germ cell tumour, or metastatic testicular cancer.
The complete removal of the GN is described as adequate therapy with an excellent prognosis. Nevertheless, surgical morbidity has to be considered. In a retrospective series of 146 children with GN, surgical tumour resection resulted in an excellent long-term survival, but, nevertheless, 22 of the 146 patients (15 %) suffered surgery-related complications, of which two were fatal and seven were severe (e.g. Horner syndrome, rupture of thoracic aorta and thoracic haemorrhage) . Residual GN after incomplete resection remains stable for years without malignant transformation . In addition, Retrosi et al. did not observe recurrences after incomplete excision in a series of 23 children with thoracic (n = 14), abdominal (n = 7) or pelvic GN (n = 3) . Surgical complication rate reached 30 % . Therefore, Retrosi and De Bernadi recommended less radical surgery in childhood GN to reduce surgery-related morbidity and mortality [5, 16]. Even a watchful waiting could be an option in selected cases after secured diagnosis. Interdisciplinary discussion and image-guided biopsy prior to surgery is recommended to prevent unnecessary expanded surgical approaches with significant postoperative morbidity. From our experience, we would suggest surgical resection of GN, but with a less radical approach in order to preserve the adjacent organs and structures where appropriate.
Ganglioneuroma is a benign, rare tumour with an excellent prognosis in long-term survival even after incomplete resection. Therefore, a limited surgical resection to prevent postoperative morbidity might be appropriate in selected cases. An image-guided biopsy prior to surgery can establish a histological diagnosis and prevent unneeded extensive surgery.
CT, computed tomography; GN, ganglioneuroma; IUD, intrauterine device; MRI, magnetic resonance imaging
Availability of data and material
Upon request and on condition of the patients consent all data and material will be available to any scientist.
All authors participated in the conception and design of the study. CP and RS drafted the manuscript. CP, EG, AS and RS participated in the care of the patient. AH and EJG offered the pathological data. CP, AH, EG, EJG, AS and RS were involved in the final editing. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication of the case report and any accompanying images.
Ethics approval and consent to participate
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer. 1999;86:349–63.View ArticlePubMedGoogle Scholar
- Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer. 1999;86:364–72.View ArticlePubMedGoogle Scholar
- Ambros IM, Hata J, Joshi VV, Roald B, Dehner LP, Tüchler H, Pötschger U, Shimada H. Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups. Cancer. 2002;94:1574–83.View ArticlePubMedGoogle Scholar
- Hayes FA, Green AA, Rao BN. Clinical manifestations of ganglioneuroma. Cancer. 1989;63:1211–4.View ArticlePubMedGoogle Scholar
- De Bernardi B, Gambini C, Haupt R, Granata C, Rizzo A, Conte M, Tonini GP, Bianchi M, Giuliano M, Luksch R, Prete A, Viscardi E, Garaventa A, Sementa AR, Bruzzi P, Angelini P. Retrospective study of childhood ganglioneuroma. J Clin Oncol. 2008;26:1710–16.View ArticlePubMedGoogle Scholar
- Lonergan GJ, Schwab CM, Suarez ES, Carlson CL. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics. 2002;22(4):911–34.View ArticlePubMedGoogle Scholar
- Geoerger B, Hero B, Harms D, Grebe J, Scheidhauer K, Berthold F. Metabolic activity and clinical features of primary ganglioneuromas. Cancer. 2001;91(10):1905–13.View ArticlePubMedGoogle Scholar
- Kulkarni AV, Bilbao JM, Cusimano MD, Muller PJ. Malignant transformation of ganglioneuroma into spinal neuroblastoma in an adult. J Neurosurg. 1998;88(2):324–7.View ArticlePubMedGoogle Scholar
- Ichikawa T, Ohtomo K, Araki T, Fujimoto H, Nemoto K, Nanbu A, Onoue M, Aoki K. Ganglioneuroma: computed tomography and magnetic resonance features. Br J Radiol. 1996;69(818):114–21.View ArticlePubMedGoogle Scholar
- Guan YB, Zhang WD, Zeng QS, Chen GQ, He JX. CT and MRI findings of thoracic ganglioneuroma. Br J Radiol. 2012;85(1016):e365–72.View ArticlePubMedPubMed CentralGoogle Scholar
- Brueck M, Bandorski D, Rauber K, Kramer W. Unilateral swollen leg caused by a retroperitoneal ganglioneuroma. Dtsch Med Wochenschr. 2006;38:2079–82.View ArticleGoogle Scholar
- Gültekin M, Dursun P, Salman C, Ozyüncü O, Saglam A, Küçükali T, Ayhan A. Ganglioneuroma mimicking ovarian tumor: a report of a case and review of the ganglioneuromas. Arch Gynecol Obstet. 2005;271:66–8.View ArticlePubMedGoogle Scholar
- Wu CS, Wang XW, Qin T, Chen Z, Sun S, Li JM, Liu HL, Feng H, Han JQ. Primary intraosseous ganglioneuromatous paraganglioma of the sacrum with immunopositivity for cytokeratin. Eur Rev Med Pharmacol Sci. 2015;19:931–5.PubMedGoogle Scholar
- Bjellerup P, Theodorsson E, Kogner P. Somatostatin and vasoactive intestinal peptide in neuroblastoma and ganglioneuroma: chromatographic characterization and release during surgery. Eur J Cancer. 1995;31A:481–5.View ArticlePubMedGoogle Scholar
- Nishinari K, Wolosker N, Yazbek G, Toshihiko W, Lopes A. Idiopathic aneurysm of inferior vena cava associated with retroperitoneal ganglioneuroma: case report. J Vasc Surg. 2003;37:895–8.View ArticlePubMedGoogle Scholar
- Retrosi G, Bishay M, Kiely EM, Sebire NJ, Anderson J, Elliott M, Drake DP, Coppi PD, Eaton S, Pierro A. Morbidity after ganglioneuroma excision: is surgery necessary? Eur J Pediatr Surg. 2011;21:33–7.View ArticlePubMedGoogle Scholar